Clinical Trial Results:
Neoadjuvant therapy for postmenopausal women with
ER and/or PgR positive breast cancer.
A randomized open phase II trial evaluating the efficacy
of a 6 months preoperative treatment with
Letrozole (2.5 mg/day) with or without
Zoledronic acid (4 mg every 4 weeks).
Summary
|
|
EudraCT number |
2004-004007-37 |
Trial protocol |
DE |
Global completion date |
16 Dec 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
03 Mar 2017
|
First version publication date |
03 Mar 2017
|
Other versions |
v2 |
Summary report(s) |
CZOL446GDE19 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.